Examination of potential inhibitors of hepatitis A virus uncoating

Intervirology

Volumn 41, Issue 6, 1998, Pages 261-271

  Bishop, Naomi E ^a,b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chloroquine; Chlorpromazine; Endocytosis; Hepatitis A virus; Lysosomotropic agents; Uncoating

Indexed keywords

AMANTADINE; AMMONIUM CHLORIDE; ANTIVIRUS AGENT; ARILDONE; CALCIUM ION; CHLOROQUINE; CHLORPROMAZINE; CLATHRIN; ISOPRENALINE; MONENSIN; PHENOTHIAZINE; RIMANTADINE; SURAMIN; VERAPAMIL;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HEPATITIS A VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CALCIUM; CELL LINE; CERCOPITHECUS AETHIOPS; CHLOROQUINE; CHLORPROMAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENDOSOMES; HEPATOVIRUS; LYSOSOMES; RNA, VIRAL; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HEPATITIS A VIRUS;

EID: 0032407127     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024948     Document Type: Article

References (63)

1. Lamaze C, Schmid SL: The emergence of clathrin-independent pinocytic pathways. Curr Opin Cell Biol 1995;7:573-580.
2. Watts C, Marsh C: Endocytosis: What goes in and how? J Cell Sci 1992;103:1-8.
3. Bishop NE: An update on non-clathrin-coated endocytosis. Rev Med Virol 1997;7:199-209.
4. Marsh M, Helenius A: Virus entry into animal cells. Adv Virus Res 1989;36:107-151.
5. Ohkuma S, Poole B: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978;75: 3327-3331.
6. Maxfield FR: Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol 1982;95:676-681.
7. 2-macroglobulin. Cell 1982;28:643-651.
8. Geisnow JJ, Evans WH: pH in the endosome: Measurements during pinocytosis and receptor-mediated endocytosis. Exp Cell Res 1984; 150:36-46.
9. Meyer WJ, Gidwitz S, Ayers VK, Shoepp RJ, Johnston RE: Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH. J Virol 1992;66: 3504-3513.
10. Svensson U: Role of vesicles during adenovirus 2 internalization into HeLa cells. J Virol 1985; 55:442-449.
11. Lonberg-Holm K, Crowell RL, Philipson L: Interaction of liposomes with subviral particles of poliovirus type 2 and rhinovirus type 2. J Virol 1976;19:746-749.
12. Fricks CE, Hogle JM: Cell-induced conformational changes in poliovirus: Externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol 1990;64:1934-1945.
13. Skern T, Torgersen H, Auer H, Kuechler E, Blaas D: Human rhinovirus mutants resistant to low pH. Virology 1991;183:757-763.
14. Froshauer S, Kartenbeck J, Helenius A: Alphavirus RNA replication occurs on the cytoplasmic surface of endosomes and lysosomes. J Cell Biol 1988;107:2075-2086.
15. Anderson HA, Chen Y, Norkin LC: Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 1996;7:1825-1834.
16. Stang E, Kartenbeck J, Parton RG: Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol Biol Cell 1997;8:47-57.
17. Nemerow GR, Wolfert R, McNaughton ME, Cooper NR: Identification of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor. J Virol 1985;55:347-351.
18. Mackay R, Consigli RA: Early events in polyoma virus infection: Attachment, penetration and nuclear entry. J Virol 1976;19:620-636.
19. Maul GG, Rovera G, Vorbrodt A, Abramczyk J: Of simian virus 40 entry into different cellular compartments. J Virol 1978;28:936-944.
20. Mandel B: The relationship between penetration and uncoating of poliovirus in HeLa cells. Virology 1967;31:702-712.
21. Dales S: An electron microscope study of the early association between two mammalian viruses and their hosts. J Cell Biol 1973;13:303-322
22. Zeichhardt H, Wetz K, Willingmann P, Habermehl KO: Entry of poliovirus type 1 and mouse Elberfeld virus into HEp-2 cells: Receptor-mediated endocytosis and endosomal or lysosomal uncoating. J Gen Virol 1985;66:281-285.
23. Madshus IH, Olsnes S, Sandvig K: Mechanism of entry into the cytosol of poliovirus type 1: Requirement for low pH. J Cell Biol 1984;98: 1194-1200.
24. Madshus IH, Olsnes S, Sandvig K: Requirements for entry of poliovirus RNA into cells at low pH. EMBO J 1984;9:1945-1950.
25. Madshus IH, Olsnes, S, Sandvig K: Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus. Virology 1984;139: 346-357.
26. Carrillo EC, Giachetti C, Campos R: Early steps in FMDV replication: Further analysis on the effects of chloroquine. Virology 1985;147: 118-125.
27. Neubauer C, Frasel L, Kuechler E, Blaas D: Mechanism of entry of human rhinovirus 2 into HeLa cells. Virology 1987;158:255-258.
28. Gromeier M, Wetz K: Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment. J Virol 1990;64:3590-3597.
29. Pérez L, Carrasco L: Entry of poliovirus into cells does not require a low-pH step. J Virol 1993;67:4543-4548.
30. Kronenberger, P, Vrijsen R, Geerts, A, Boeyé A: Internalization of intact poliovirus by HeLa cells as shown by subcellular fractionation in isoosmotic Nycodenz gradients. J Gen Virol 1992;73:597-605.
31. Wetz K, Kucinski T: Influence of different ionic and pH environments on structural alterations of poliovirus and their possible relation to virus uncoating. J Gen Virol 1991;72:2541-2544.
32. Widell A, Hansson BG, Öberg B, Nordenfelt E: Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral Res 1986;6:103-112.
33. Superti F, Seganti L, Orsi N, Divizia M, Gabrieli R, Paná A: The effect of lipophilic amines on the growth of hepatitis A virus in Frp/3 cells. Arch Virol 1987;96:289-296.
34. Superti F, Seganti L, Orsi N, Divizia M, Gabrieli R, Paná A: Effect of cellular function inhibitors on the infection of Frp/3 cells by hepatitis A virus. Med Microbiol Immunol 1989;178:29-36.
35. Bishop NE, Hugo DL, Borovec SV, Anderson DA: Rapid and efficient purification of hepatitis A virus from cell culture. J Virol Methods 1993;47:203-216.
36. Anderson DA, Coulepis AG, Chenoweth MP, Gust ID: Indirect immunofluorescence assay for the detection of hepatitis A virus-specific serum immunoglobulins. J Clin Microbiol 1986;24:163-165.
37. Anderson DA, Ross BC, Locarnini SA: Restricted replication of hepatitis A virus in cell culture: Encapsidation of viral RNA depletes the pool of RNA available for replication. J Virol 1988;62:4201-4206.
38. Anderson DA, Ross BC: Morphogenesis of hepatitis A virus: Isolation and characterization of subviral particles. J Virol 1990;64: 5284-5289.
39. Lemon SM, Binn LN, Marchwicki RH: Radioimmunofocus assay for quantitation of hepatitis A virus in cell culture. J Clin Microbiol 1983;17:834-839.
40. Anderson DA, Locarnini SA, Ross BC, Coulepis AG, Anderson BN, Gust ID: Single cycle growth kinetics of hepatitis A virus in BS-C-1 cells; in Brinton MA, Rueckert RR (eds): Positive Strand RNA Viruses. New York, Liss, 1987, pp 497-507.
41. Seglen O: Inhibitors of lysosomal function. Methods Enzymol 1983;96:737-764.
42. Diana GD, Salvador UJ, Zalay ES, Carabateas PM, Williams GL, Collins JE, Pancic F: [[(4, 5-dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles: Inhibitors of picornavirus uncoating. J Med Chem 1977;28:1906-1910.
43. McSharry JJ, Caliguiri LA Eggers HJ: Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology 1979;97:307-315.
44. Petcu DJ, Aldrich CE, Coates L, Taylor JM, Mason WS: Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology 1988;167: 385-392.
45. Wheeler CM, Fields HA, Schable CA, Meinke WJ, Maynard JE: Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15. J Clin Microbiol 1986;23:434-440.
46. Borovec SV, Anderson DA: Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells. J Virol 1993;67:3095-3102.
47. Smith TJ, Kremer MS, Luo M, Vriend G, Arnold E, Kamer G, Rossmann MG, McKinlay MA, Diana GD, Otto MJ: The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 1986; 233:1286-1293.
48. Zeichhardt H, Otto MJ, McKinlay MA, Willingmann P, Habermehl K-O: Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology 1987;160:281-285.
49. Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991;164:1098-1103.
50. Zajac AJ, Amphlett EM, Rowlands DJ, Sangar DV: Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines. J Gen Virol 1991;72:1667-1675.
51. Bishop NE, Anderson DA: Early interactions of hepatitis A virus with cultured cells: Viral elution and the effect of pH and calcium ions. Arch Virol 1997;142:2161-2178.
52. Kronenberger P, Vrijsen R, Boeyé A: Chloroquine induces empty capsid formation during poliovirus eclipse. J Virol 1991;65:7008-7011.
53. Dimmock NJ: Initial stages in infection with animal viruses. J Gen Virol 1982;59:1-22.
54. Coombs K, Mann E, Edwards J, Brown DT: Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J Virol 1981;37:1060-1065.
55. Nemerow GR, Cooper NR: Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by a calmodulin antagonist. Proc Natl Acad Sci USA 1984;81:4955-4959.
56. Madshus IH, Sandvig K, Olsnes S, van Deurs B: Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses. J Cell Physiol 1987;131:14-22.
57. Okanoue T, Kondon E, Ihrig TJ, French SW: Effect of ethanol and chlorpromazine on transhepatic transport and biliary secretion of horseradish peroxidase. Hepatology 1984;4:253-260.
58. Salisbury JL, Condeelis JS, Satir P: Evidence for the involvement of calmodulin in endocytosis. Ann NY Acad Sci 1980;356:429-432.
59. Seigneurin NM, Villaume M, Lenoir G, de The G: Replication of Epstein-Barr virus: Ultrastructural and immunofluorescent studies of P3HRI-superinfected Raji cells. J Virol 1977; 24:835-845.
60. Nemerow GR, Cooper NR: Early events in the infection of human B lymphocytes by Epstein-Barr virus: The internalization process. Virology 1984;132:186-198.
61. Miller N, Hutt-Fletcher LM: Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol 1992;66:3409-3414.
62. Siegl G, Weitz M, Kronauer G: Stability of hepatitis A virus. Intervirology 1984;22:218-226.
63. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F: The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 1989;337:709-716.